Outsourced Pharma Newsletter - Naked Leadership: Stripped To Results In BioPharma

Industry Analysis Naked Leadership: Stripped To Results In BioPharma By Louis Garguilo, Executive Editor, Outsourced Pharma An investigation into the modern-day minimalist verdict of leadership and its accepted measurement. It’ll require a three-point thought experiment. FROM THE EDITOR: Hiring A Chief Medical Officer May Sound Good, But... By Ed Miseta, Chief Editor, Outsourced Pharma Laurie Halloran has seen many firms succeed where others have failed. She will tell you how she started her company after speaking to many executives about how to grow their companies, get funding, make it through clinical testing, and finally going commercial. » Drug Substance/Drug Product Manufacturing ARTICLE: The Supply Chain Of The Future: A Strategic View By Ed Miseta, Chief Editor, Outsourced Pharma Evolutionary theory teaches us it is neither the strongest nor the most intelligent of the species that survives. It is the one that is the most adaptable to change. Peter Bigelow, president of xcell Strategic Consulting, likes to mention this quote, widely attributed to Charles Darwin, when opening presentations on the future of the pharmaceutical supply chain. FROM THE EDITOR: Dow Assists Drug Delivery With Excipients And Outsourcing By Louis Garguilo, Executive Editor, Outsourced Pharma Dow Pharma & Food Solutions (DP&FS) has focused intently on improving a specific area of the pharmaceutical industry: solubility, and thus bioavailability, in new and existing drugs. In Dow’s advancement and supplying of polymers as excipients, it works hand-in-hand with outsourcing service providers. But don’t call Dow itself a provider. » Discovery Research/Preclinical Development ARTICLE: Best Practices For Successful Bioanalytical Methods Transfer By Roger Hayes, Ph.D., Vice President and General Manager of Laboratory Services, MPI Research From bench to bedside, developing a new drug requires many years and many hands. Each step must be taken carefully to ensure the quality and integrity of the process. This is of special importance in bioanalytical methods transfer. » Drug Development WHITE PAPER: Retake Control, Shorten Cycle Times, And Cut Costs With Insourcing By Michael P. Trova, Ph.D., Senior Vice President, Chemistry, Albany Molecular Research Inc. (AMRI) While many companies enjoy unproblematic outsourcing relationships, there are others that are still struggling to make the benefits outweigh the costs. Stuck between an in-house approach that was ineffective in the past and an outsourced model that is burdensome today, an interest in insourcing continues to expand. GUEST COLUMN: Just How Big Is Big Data? By Nick Burch, CTO, Quanticate Despite all of this interest, a great deal of confusion remains around Big Data. Not only are there never-ending debates about what Big Data is, there's a huge range of possible Big Data solutions out there to choose from, only a few of which will be appropriate for any given situation or problem. » Packaging/Assembly/Logistics WHITE PAPER: Realizing Business Productivity Through Supply Chain Segmentation WHITE PAPER: Improving Corrective And Preventive Measures In The Pharma Supply Chain ARTICLE: A Growing Number Of Pharmas Are Thinking Outside The Box ARTICLE: As Cold Chain Logistics Demands Grow, Technology Becomes Critical CASE STUDY: A Smart Choice For The Cold Chain CASE STUDY: Continuous Monitoring System Brings Peace Of Mind INFOGRAPHIC: Mystery Meds: Counterfeit Drugs Remain A Supply Chain Risk In Emerging Markets » Most Recent News Launch Of Turing Pharmaceuticals Announced - New Drug Company To Focus On Treating Unmet Medical Needs Across Broad Therapeutic Areas Alzheimer's Disease Treatment Pipeline Remains Large Despite 95% Attrition Rate, Says GBI Research Canada's Valeant To Buy Salix In $10.1B Deal » Subscribe Today For insight on how pharma and biopharm executives can improve how they run their businesses, subscribe to Life Science Leader magazine.